3,5-二对甲苯基-4,5-二氢-1H-吡唑-1-硫代甲酰胺 | 153332-11-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3,5-二对甲苯基-4,5-二氢-1H-吡唑-1-硫代甲酰胺
• 英文名称: 3,5-Dip-tolyl-4,5-dihydro-1H-pyrazole-1-carbothioamide
• 英文别名: 3,5-bis(4-methylphenyl)-3,4-dihydropyrazole-2-carbothioamide
• CAS: 153332-11-7
• 化学式: C₁₈H₁₉N₃S
• 分子量: 309.435
• InChiKey: IXWUIEQWLIZCLY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  73.7
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3,5-二对甲苯基-4,5-二氢-1H-吡唑-1-硫代甲酰胺 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 37.0h， 生成 3-(2-(3,5-di-p-tolyl-4,5-dihydro-1H-pyrazol-1-yl)thiazole-5-carbonyl)-8-hydroxy-2H-chromen-2-one
  参考文献：
  名称：

  Triad pyrazole–thiazole–coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis

  摘要：

  DOI：

  10.1080/07391102.2023.2181643
• 作为产物：
  描述：

  对甲基苯甲醛 在 potassium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 12.0h， 生成 3,5-二对甲苯基-4,5-二氢-1H-吡唑-1-硫代甲酰胺
  参考文献：
  名称：

  Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors

  摘要：

  A series of pyrazolyl-thiazolinone derivatives (E1-E36) have been designed and synthesized and their biological activities were also evaluated as potential EGFR and HER-2 kinase inhibitors. Thirty-four of the 36 compounds were reported for the first time. Among them, compound 2-(5-(4-bromophenyl)-3-p-tolyl-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4(5H)-one (E28) displayed the most potent inhibitory activity (IC50 = 0.24 mu M for EGFR and IC50 = 1.07 mu M for HER-2). Antiproliferative assay results indicated that compound E28 owned high antiproliferative activity against MCF-7, B16-F10 and HCT-116 in vitro, with IC50 value of 0.30, 0.54, and 0.70 mu M, respectively. Docking simulation was further performed to position compound E28 into the EGFR active site to determine the probable binding model. Based on the preliminary results, compound E28 with potent inhibitory activity in tumor growth would be a potential anticancer agent. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.01.051

文献信息

• Synthesis, Molecular Modeling Studies, and Selective Inhibitory Activity against Monoamine Oxidase of 1-Thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1<i>H</i>)- pyrazole Derivatives
  作者：Franco Chimenti、Elias Maccioni、Daniela Secci、Adriana Bolasco、Paola Chimenti、Arianna Granese、Olivia Befani、Paola Turini、Stefano Alcaro、Francesco Ortuso、Roberto Cirilli、Francesco La Torre、Maria C. Cardia、Simona Distinto

  DOI：10.1021/jm040903t

  日期：2005.11.1

  The separated enantiomers were then submitted to in vitro biological evaluation. The selectivity of the (-)-(S)-1 enantiomer against MAO-B increases twice and a half, while the selectivity of the (-)-(S)-4 enantiomer against MAO-A triples. Both the MAO-A and MAO-B isoforms respectively of the 1O5W and 1GOS models deposited in the Protein Data Bank were considered in the computational study. The docking

  合成了一系列新型的1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-（1H）-吡唑衍生物，并研究了选择性抑制单胺氧化酶A和B同工型（MAO）活性的能力。 ）。所有合成的化合物均显示出对MAO-A和MAO-B同种型均具有高活性，Ki值分别在27和4 nM之间以及在50和1.5 nM之间，除了一些对MAO-B具有抑制活性的衍生物。微摩尔范围。知道立体化学可能是生物活性的重要调节剂，我们进行了最有效，选择性和手性化合物的半制备色谱对映体分离。然后将分离的对映异构体进行体外生物学评估。（-）-（S）-1对映体对MAO-B的选择性提高了两倍半，而（-）-（S）-4对映体对MAO-A的选择性则提高了三倍。在计算研究中考虑了分别存放在蛋白质数据库中的1O5W和1GOS模型的MAO-A和MAO-B亚型。对接研究是使用几种计算方法进行的，目的是提出MAO对映选择性化合物1和4的可能结合方式。
• Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors
  作者：Ke-Ming Qiu、Hai-Hong Wang、Li-Ming Wang、Yin Luo、Xian-Hui Yang、Xiao-Ming Wang、Hai-Liang Zhu

  DOI：10.1016/j.bmc.2012.01.051

  日期：2012.3

  A series of pyrazolyl-thiazolinone derivatives (E1-E36) have been designed and synthesized and their biological activities were also evaluated as potential EGFR and HER-2 kinase inhibitors. Thirty-four of the 36 compounds were reported for the first time. Among them, compound 2-(5-(4-bromophenyl)-3-p-tolyl-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4(5H)-one (E28) displayed the most potent inhibitory activity (IC50 = 0.24 mu M for EGFR and IC50 = 1.07 mu M for HER-2). Antiproliferative assay results indicated that compound E28 owned high antiproliferative activity against MCF-7, B16-F10 and HCT-116 in vitro, with IC50 value of 0.30, 0.54, and 0.70 mu M, respectively. Docking simulation was further performed to position compound E28 into the EGFR active site to determine the probable binding model. Based on the preliminary results, compound E28 with potent inhibitory activity in tumor growth would be a potential anticancer agent. (C) 2012 Elsevier Ltd. All rights reserved.
• Triad pyrazole–thiazole–coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis
  作者：Mehmet Gümüş、İrfan Koca、Yusuf Sert、Ali Dişli、Ezgi Nurdan Yenilmez Tunoğlu、Lütfi Tutar、Yusuf Tutar

  DOI：10.1080/07391102.2023.2181643

  日期：——